Company Filing History:
Years Active: 2007-2010
Title: Innovations by James Rusnak in Cardiovascular and Immune Disorder Treatments
Introduction
James Rusnak is an accomplished inventor based in Newtown, PA (US). He has made significant contributions to the field of medical science, particularly in the treatment of cardiovascular diseases and immune disorders. With a total of three patents to his name, Rusnak's work has the potential to impact many lives.
Latest Patents
Rusnak's latest patents include innovative methods for treating cardiovascular disease using a soluble CTLA4 molecule. This invention relates to compositions and methods for treating cardiovascular system diseases by administering soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands. Another notable patent focuses on methods for treating immune disorders associated with graft transplantation using soluble CTLA4 mutant molecules. This invention provides the use of soluble CTLA4 mutant molecules that bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or non-mutated CTLA4Ig in the treatment of immune disorders associated with graft transplantation.
Career Highlights
James Rusnak is currently employed at Bristol-Myers Squibb Company, a leading biopharmaceutical company. His work at this organization allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
One of his notable coworkers is David Hagerty, with whom he collaborates on various projects related to his patents and research.
Conclusion
James Rusnak's innovative work in the medical field, particularly in cardiovascular and immune disorder treatments, showcases his dedication to improving healthcare. His patents reflect a commitment to advancing medical science and providing solutions for complex health issues.